Classic publications

Up one level

1993

• Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension

1991

• Hypothesis. The hemodynamic link between insulin resistance and hypertension

1990

• The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study
• "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan

1989

• The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

1988

• Banting lecture 1988. Role of insulin resistance in human disease

1985

• Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance

1974

• Insulin secretion in hyperlipoproteinemias

1967

• Associazione di iperlipemia, diabete mellito e obesità di medio grado.

Metabolic Syndrome and Cardiovascular Disease

• Association of the metabolic syndrome with history of myocardial infarction and stroke in the third National Health and nutrition examination survey - 2004
  Author(s) : Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS.
  Reference : Circulation 109:42-46, 2004
• NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. - 2003
  Author(s) : Alexander CM, Landsman PB, Teutsch SM, Haffner SM, Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP).
  Reference : Diabetes 52:1210-1214, 2003.
• The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). - 2004
  Author(s) : Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M; 4S Group and the AFCAPS/TexCAPS Research Group.
  Reference : Am J Cardiol. 2004 Jan 15;93(2): 136-41.
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. - 2002
  Author(s) : Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT.
  Reference : JAMA 288: 2709-2716, 2002.
• Cardiovascular morbidity and mortality associated with the metabolic syndrome. - 2001
  Author(s) : Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L.
  Reference : Diabetes Care 24:683-689, 2001.

Metabolic Syndrome and Definition/Clinical Assessment

• Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. - 2004
  Author(s) : Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association.
  Reference : Circulation. 109:551-556, 2004.
• Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. - 2004
  Author(s) : Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute.
  Reference : Circulation 109:433-438, 2004.
• Executive Summary of the Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults - 2002
  Author(s) : National Cholesterol Education Program (Adult Treatment Panel III). Final report.
  Reference : Circulation 106:3143-3421, 2002.
• Banting lecture 1988. Role of insulin resistance in human disease. - 1988
  Author(s) : Reaven GM.
  Reference : Diabetes 37:1595-1607, 1988.
• Associazione di iperlipemia, diabete mellito e obesità di medio grado. - 1967
  Author(s) : Avogaro P, Crepaldi G, Enzi G, Tiengo A.
  Reference : Acta Diabetol Lat 4:572-590, 1967.

Metabolic Syndrome and Diabetes (Including Glucose-Insulin Homeostasis)

• Executive Summary of the Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults - 2002
  Author(s) : National Cholesterol Education Program (Adult Treatment Panel III). Final report.
  Reference : Circulation 106:3143-3421, 2002.

Metabolic Syndrome and Epidemiology

• The incidence and persistence on the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study - 2003
  Author(s) : Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, Tichet J, Eschwege E
  Reference : D.E.S.I.R. Study Group. Diabetes Metab 29:526-532, 2003
• Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. - 2002
  Author(s) : Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B
  Reference : European Group For The Study Of Insulin Resistance (EGIR). Diabetes Metab 28:364-376, 2002.
• Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. - 2004
  Author(s) : Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group.
  Reference : Arch Intern Med. 2004 May 24;164(10):1066-76.
• Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. - 2003
  Author(s) : Meigs JB, Wilson PWF, Nathan DM, D’Agostino RB Sr, Williams K, Haffner SM.
  Reference : Diabetes 52: 2160-2167, 2003.
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. - 2002
  Author(s) : Ford ES, Giles WH, Dietz WH.
  Reference : PMID:11790215

Metabolic Syndrome and Hypertension

• Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. - 2001
  Author(s) : Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton D, Karanja N, Lin PH; DASH-Sodium Collaborative Research Group.
  Reference : N Engl J Med 344:3-10, 2001.
• Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension. - 1993
  Author(s) : Julius S.
  Reference : Hypertension 21:886-893, 1993.
• Reflex sympathetic activation induces acute insulin resistance in the human forearm. - 1993
  Author(s) : Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO.
  Reference : Hypertension 21:618-623, 1993.
• Hypothesis. The hemodynamic link between insulin resistance and hypertension. - 1991
  Author(s) : Julius S, Gudbrandsson T, Jamerson K, Shahab ST, Andersson O.
  Reference : J Hypertension 9:983-986, 1991.
• "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. - 1990
  Author(s) : Julius S, Mejia A, Jones K, Krause L, Schork N, van de Ven C, Johnson E, Petrin J, Sekkarie MA, Kjeldsen, SE, Schmouder R, Gupta R, Ferraro J, Nazzaro P, Weissfeld J.
  Reference : Hypertension 16:617-623, 1990.

Metabolic Syndrome and Inflammation

• Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR - 2004
  Author(s) : Chinetti G, Zawadski C, Fruchart JC, Staels B
  Reference : Biochem Biophys Res Commun 314:151-158, 2004
• Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? - 2004
  Author(s) : Ridker PM, Wilson PW, Grundy SM.
  
  Reference : Circulation. 2004 Jun 15;109(23):2818-2825.
• Adiponectin and metabolic syndrome. - 2004
  Author(s) : Matsuzawa Y, Funahashi T, Shimomura I.
  Reference : Arterioscler Thromb Vasc Biol 24:29-33, 2004.

Metabolic Syndrome and Lifestyle Habits (Including Nutrition/Physical Activity)

• A randomized controlled trial of a moderate-fat, low-energy diet compared with a low fat, low-energy diet for weight loss in overweight adults. - 2001
  Author(s) : McManus K, Antinoro L, Sacks F.
  Reference : J Obes Relat Metab Disord 25:1503-1511, 2001.

Metabolic Syndrome and Lipoproteins/Lipids

• Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5 - 2004
  Author(s) : Fruchart-Najib J, Baugé E, Niculescu LS, Pham T, Thomas B, Rommens C, Majd Z, Brewer B, Pennacchio LA, Fruchart JC.
  Reference : Biochem Biophys Res Commun 319:397-404, 2004
• LDL particles containing apolipoprotein C-III are independent risk factors for coronary events in diabetic patients. - 2003
  Author(s) : Lee SJ, Campos H, Moye LA, Sacks FM.
  Reference : Arterioscler Thromb Vasc Biol 23:853-858, 2003.
• Low density lipoprotein size and cardiovascular disease: a reappraisal. (Clinical Review 163). - 2003
  Author(s) : Sacks FM and Campos H.
  Reference : J Clin Endocrinol Metab 88:4525-4532, 2003.
• The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations - 2002
  Author(s) : Sacks FM for the HDL Expert Group on HDL cholesterol.
  Reference : J Cardiol 90:139-143, 2002.
• Peripheral rather than hepatic, insulin resistance and atherogenic lipoprotein phenotype predict cardiovascular complications in NIDDM - 1994
  Author(s) : Nosadini R, Manzato E, Solini A, Fioretto P, Brocco E, Zambon S, Morocutti A, Sambataro M, Velussi M, Cipollina M., Crepaldi G
  Reference : Eur J Clin Invest 24:258-266, 1994.

Metabolic Syndrome and Obesity

• New criteria for "obesity disease" in Japan. - 2002
  Author(s) : The Examination Committee of Criteria for "Obesity Disease" in Japan, Japan Society for the Study of Obesity.
  Reference : Circ J 66:987-992, 2002.
• Establishing the concept of visceral fat syndrome and clarifying its molecular mechanisms. - 2002
  Author(s) : Matsuzawa Y.
  Reference : JMAJ 45:103-110, 2002.
• The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension - 1989
  Author(s) : Kaplan NM.
  Reference : Arch Intern Med 149:1514-1520, 1989.

Metabolic Syndrome and Pathophysiology

• Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. - 1985
  Author(s) : M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z.
  Reference : Clin Invest 75:809-817, 1985.